| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/25/2004 | EP1448235A1 Pharmaceutical compositions of 5,7,14-triazatetracyclo 10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene |
| 08/25/2004 | EP1448234A1 Formulations comprising a cephalosporin compound and their use in treating bacterial infections in cats and dogs |
| 08/25/2004 | EP1448231A1 Topical delivery of codrugs |
| 08/25/2004 | EP1448228A2 Management of postoperative pain |
| 08/25/2004 | EP1448227A2 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 08/25/2004 | EP1448224A2 Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases |
| 08/25/2004 | EP1448221A1 Injection solution comprising an lhrh antagonist |
| 08/25/2004 | EP1448214A2 Ginger extract preparation |
| 08/25/2004 | EP1448209A2 A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 08/25/2004 | EP1448204A1 New dry and aqueous epinastine-syrup-formulation |
| 08/25/2004 | EP1448203A1 Pharmaceutical formulations comprising substituted xanthine compounds |
| 08/25/2004 | EP1448186A1 Medicament for the treatment of viral skin and tumour diseases |
| 08/25/2004 | EP1448182A1 Pharmaceutical compositions and methods for administering ep 2 receptor selective agonists |
| 08/25/2004 | EP1448175A1 Transdermal therapeutic systems containing steroid hormones and propylene glycol monocaprylate |
| 08/25/2004 | EP1448174A2 Water soluble nanoparticles of hydrophilic and hydrophobic active materials |
| 08/25/2004 | EP1448172A1 Surface coated capsules |
| 08/25/2004 | EP1448171A2 Pharmaceutical formulation comprising more than 15% tamoxifen |
| 08/25/2004 | EP1448169A1 Method for improving dissolution of poorly dispersible medicaments |
| 08/25/2004 | EP1448168A1 Pharmaceutical formulation comprising bicalutamide |
| 08/25/2004 | EP1448167A1 New use of ethoxylated phytosterols and phytostanols |
| 08/25/2004 | EP1448166A1 Controlled release polymeric compositions of bone growth promoting compounds |
| 08/25/2004 | EP1448101A2 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility |
| 08/25/2004 | EP1448053A2 Proliferation and differentiation of stem cells using extracellular matrix and other molecules |
| 08/25/2004 | EP1360957A4 Vitamin/mineral complex |
| 08/25/2004 | EP1299132B1 Limiting the presence of microorganisms using polymer-bound metal-containing compositions |
| 08/25/2004 | EP1289506B1 Process for producing a stable micronized composition of formoterol with a glucocorticosteroid |
| 08/25/2004 | EP1248838A4 Polyampholytes for delivering polyions to a cell |
| 08/25/2004 | EP1094790B1 Sustained release pharmaceutical preparation comprising phenytoin sodium |
| 08/25/2004 | EP1084270B1 Methods for assaying clotting in plasma |
| 08/25/2004 | EP1083881B1 LIPOSOME COMPOSITIONs containing a quinolone derivative AND their use as antibacterial agents |
| 08/25/2004 | EP1082138B1 Texaphyrin conjugates and uses thereof |
| 08/25/2004 | EP1037938B1 Use of hyperbranched polymers or dendrimers having a particular group as thickening or gelling agent |
| 08/25/2004 | EP1037657A4 Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
| 08/25/2004 | EP0918541B1 Immunstimulating lipid formulation |
| 08/25/2004 | EP0881906B1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/25/2004 | EP0826051B1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
| 08/25/2004 | CN1524125A 化合物 Compound |
| 08/25/2004 | CN1524124A Fibrin/fibrinogen-binding conjugate |
| 08/25/2004 | CN1524123A A soluble complex comprising a retroviral surface glycoprotein |
| 08/25/2004 | CN1523998A Sustained-release compositions for injection and process for producing the same |
| 08/25/2004 | CN1523997A Stabilized interleukin 2 |
| 08/25/2004 | CN1523985A Preparation of formulations of angiotensin ii at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illnesses and its complications |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1523980A Pharmaceutical preparation comprising an active dispersed on a matrix |
| 08/25/2004 | CN1523979A Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/25/2004 | CN1522763A Anti-tumour magnetic targeted slow release carrier iron-carbon composite material and its preparation method |
| 08/25/2004 | CN1522755A Solid formulation containing isomaltone itol, its preparation method and uses |
| 08/25/2004 | CN1522697A Prevention of migraine recurrence |
| 08/25/2004 | CN1522692A Pressurized metered dose inhalers and pharmaceutical aerosol fomulations |
| 08/25/2004 | CN1522687A Oral health product using adhesive material as carrier |
| 08/25/2004 | CN1163509C RET ligand (RetL) for stimulating neural and renal growth |
| 08/25/2004 | CN1163288C Process for manufacture of amorphous products by means of convection drying |
| 08/25/2004 | CN1163275C Biofunctional polymers prepared in supercritical fluid |
| 08/25/2004 | CN1163274C Molded articles and method of producing the same |
| 08/25/2004 | CN1163265C Pharmaceutical formulations of nerve growth factor |
| 08/25/2004 | CN1163264C Pharmaceutical compositions |
| 08/25/2004 | CN1163260C Ionic molecular conjugates of biodergaable polyesters and bioactive polypeptides |
| 08/25/2004 | CN1163233C Intra-cancer-cell nuclease activator |
| 08/25/2004 | CN1163232C Fatty emulsing containing reducing sugar and method for sterilizing same |
| 08/25/2004 | CN1163229C Chemical graft anti-gonococcus medicinal soluble cotton yarn, and it preparation method |
| 08/25/2004 | CN1163220C Tablet for instant and prolonged release of one or more active substances |
| 08/25/2004 | CN1163200C Steam generating pad |
| 08/24/2004 | US6782307 Method for producing customized cosmetic and pharmaceutical formulations on demand |
| 08/24/2004 | US6781011 Bone-related and various other diseases |
| 08/24/2004 | US6780889 Prepared by mixing gamma-hydroxybutyrate and a ph-adjusting agent in an aqueous medium |
| 08/24/2004 | US6780885 Pharmacologically active compounds may be administered to vertebrates by diluting the formulation in the drinking water of the vertebrate |
| 08/24/2004 | US6780882 Substituted benzimidazole dosage forms and method of using same |
| 08/24/2004 | US6780881 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 08/24/2004 | US6780852 Oxidized and reduced starch exhibits longer vascular half-life, slower degradation by amylase, and/or slower clearance from an animal than unmodified starch; parental injections |
| 08/24/2004 | US6780850 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood |
| 08/24/2004 | US6780847 Nucleotide sequences coding polypeptide for use in the treatment and prevention of viral infections |
| 08/24/2004 | US6780846 Membrane translocating peptide drug delivery system |
| 08/24/2004 | US6780844 Calcium phosphopeptide complexes |
| 08/24/2004 | US6780628 Enzyme treatment |
| 08/24/2004 | US6780508 Powder particles with smooth surface for use in inhalation therapy |
| 08/24/2004 | US6780504 Covering, active material and adhesive; spraying |
| 08/24/2004 | US6780443 Combination of cooling, warming and tingling agents for such as mouthwashes; employs jambu oleoresin and/or spilanthol; long lasting |
| 08/24/2004 | US6780436 Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound |
| 08/24/2004 | US6780435 Pellet comprising inert core component, omeprazole, surface active agent, filler, alkaline agent, binder and single layer of enteric coating |
| 08/24/2004 | US6780434 Controlled release of metal cation-stabilized interferon |
| 08/24/2004 | US6780433 Using high-shear aqueous wet granulation with fluid-bed drying to form tablets of olanzapine having polymer coating; stability and prevents discoloration; for treatment of schizophrenia, mild anxiety, gastrointestinal disorders, and |
| 08/24/2004 | US6780430 Stabilzation method of nano-sized emulsion using tocopheryl derivatives and external application for skin containing the same |
| 08/24/2004 | US6780428 Loaded drugs can be physically retained in the micelles when the ph of the surrounding medium favors interactions with the core. upon a change in ph, modification in the ionization state of the core will decrease the interactions |
| 08/24/2004 | US6780427 Superoxide dismutase or other antioxidant are directly applied in combination with polymeric hydrogels at local sites of tissue injury to prevent or decrease formation of adhesions and undesirable proliferation of cells |
| 08/24/2004 | US6780425 In situ formation of transdermal delevery system; coating with drug containing cyanoacrylate adhesive liquid or gel and curing |
| 08/24/2004 | US6780421 Vaccine composition comprising at least one antigen and adjuvanting amount of 3-beta-(n-(n',n'-dimethylaminoethane)carbamoyl) cholesterol |
| 08/24/2004 | US6780413 Immunotoxin (mAB-RICIN) for the treatment of focal movement disorders |
| 08/24/2004 | US6780400 Delivery of antiemetics through an inhalation route |
| 08/24/2004 | US6780399 Delivery of stimulants through an inhalation route |
| 08/24/2004 | US6780398 Aqueous nasal formulation |
| 08/24/2004 | US6780324 Preparation of sterile stabilized nanodispersions |
| 08/19/2004 | WO2004070019A2 Membrane active polymers |
| 08/19/2004 | WO2004070012A2 Cell-killing molecules and methods of use thereof |
| 08/19/2004 | WO2004070009A2 Targeted multivalent macromolecules |
| 08/19/2004 | WO2004069876A2 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | WO2004069862A1 Peptide conjugate |
| 08/19/2004 | WO2004069294A1 Injectable gel-forming compositions based on cross-linked and non-cross-linked polymers and the use thereof |
| 08/19/2004 | WO2004069283A1 Echogen microparticles essentially used as a contrast agent for ultrasound exploration and/or as emboli for ultrasound detection |
| 08/19/2004 | WO2004069280A1 Pharmaceutical inclusion complexes containing a steroid and optionally an antibacterial agent |
| 08/19/2004 | WO2004069279A1 Composition for intracellular transport of biological particles or macromolecules |